MedPath

OSPOLOT 20 MG/ML SUSPENSIÓN ORAL

OSPOLOT 20 MG/ML SUSPENSIÓN ORAL

Pending
Register Number

89631

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Dec 30, 2024

Dosage Form

SUSPENSIÓN ORAL

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number89631
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

SULTIAMOActive
Quantity: 20 mg/ml
Name: SULTIAMO

ATC CLASSIFICATION (3)

N03A
N03AX
N03AX03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.